Xiao-Fan Wang

Title: Innovations by Inventor Xiao-Fan Wang

Introduction

Xiao-Fan Wang is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of cancer therapy and molecular biology. With a total of 2 patents, his work focuses on innovative treatments for diseases associated with the Epstein-Barr virus.

Latest Patents

One of his latest patents is titled "Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated cancers." This patent provides compositions comprising anti-LMP2 TCR-T cell populations aimed at treating EBV-associated cancers, along with methods for making and using these compositions. Another notable patent involves "Nucleic acids encoding a TGF-.beta. type 1 receptor." This patent includes isolated DNAs, such as cDNAs or genomic fragments, that encode TGF-.beta. type I receptors, as well as vectors or cells containing these DNAs and the polypeptides they encode.

Career Highlights

Xiao-Fan Wang has worked at esteemed institutions, including Duke University and The General Hospital Corporation. His research has significantly advanced the understanding and treatment of various cancers.

Collaborations

He has collaborated with notable colleagues, including Patricia K Donahoe and Michael Gustafson, contributing to a rich environment of innovation and discovery.

Conclusion

Xiao-Fan Wang's contributions to cancer therapy and molecular biology highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in medical science.